You are here

• Home
• Therapy Areas
• Cardiovascular

• A Randomised, Two Way Cross-over, Single-Blind, Phase I Study to Evaluate 24-hr Glucose Profiles in Patients with T2DM when Dosed OD and BD on Top of Metformin for Four Days with AZD1656

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Jan 30, 2009

Study Name

D1020C00017

Study Id

D1020C00017

ClinicalTrials.gov ID

NCT00819884

Recruiting Status

Closed

Protocol Status

Not Available

Report

Sep 9, 2009

• D1020C00017.pdf (507 KB)

Page tools

• Print
• Bookmark this page